Fil LTD Heron Therapeutics, Inc. Transaction History

Fil LTD

  • $103 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 08, 2021
SELL
$14.61 - $22.14 $7.03 Million - $10.7 Million
-481,200 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$13.67 - $17.77 $13 Million - $16.9 Million
-950,835 Reduced 66.4%
481,200 $7.13 Million
Q2 2020

Aug 13, 2020
SELL
$10.89 - $21.47 $11.3 Million - $22.3 Million
-1,039,208 Reduced 42.05%
1,432,035 $21.1 Million
Q1 2020

May 14, 2020
BUY
$10.23 - $24.56 $3.03 Million - $7.27 Million
296,078 Added 13.61%
2,471,243 $29 Million
Q4 2019

Feb 07, 2020
BUY
$17.42 - $26.61 $6.58 Million - $10.1 Million
377,940 Added 21.03%
2,175,165 $51.1 Million
Q3 2019

Nov 13, 2019
BUY
$16.36 - $21.39 $4.64 Million - $6.07 Million
283,590 Added 18.74%
1,797,225 $33.2 Million
Q2 2019

Aug 13, 2019
SELL
$16.93 - $26.22 $4.62 Million - $7.15 Million
-272,673 Reduced 15.26%
1,513,635 $28.1 Million
Q1 2019

May 13, 2019
SELL
$23.15 - $28.34 $11.1 Million - $13.6 Million
-481,546 Reduced 21.23%
1,786,308 $43.7 Million
Q4 2018

Feb 13, 2019
SELL
$22.03 - $32.01 $17.5 Million - $25.5 Million
-795,529 Reduced 25.97%
2,267,854 $58.8 Million
Q3 2018

Nov 09, 2018
BUY
$30.0 - $40.85 $3.1 Million - $4.22 Million
103,224 Added 3.49%
3,063,383 $97 Million
Q2 2018

Aug 10, 2018
BUY
$26.4 - $42.0 $78.1 Million - $124 Million
2,960,159 New
2,960,159 $115 Million

Others Institutions Holding HRTX

# of Institutions
176
Shares Held
121M
Call Options Held
80.4K
Put Options Held
94.9K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $210M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Fil LTD Portfolio

Follow Fil LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email